Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors
Financing Fuels the Company’s Hypergrowth to Make Elevated Care Accessible to More Patients
Petrovic’s Appointment Positions Imperative Care for Long Term Success and Scale
The financing was led by
“We are grateful for the continued support of our existing investors and welcome our new investors who share our vision for leadership in stroke and vascular thrombectomy,” said
“As investors in Imperative Care since the company’s Series C financing in
After the initial closing and subject to the discretion of the Company, there may be additional closings of this Series E financing, raising up to
Appointment of
The company also announced the appointment of
Petrovic also serves on the Boards of
“It has been a privilege to benefit from Shacey’s business acumen and strategic mastery as we position Imperative Care for long term success and scale,” Khosravi said. “On behalf of our Board of Directors, I would like to congratulate Shacey on her appointment to Vice Chair as we continue to build the thrombectomy company of the future with the patient at the center.”
“I am excited to step into this new leadership role as Imperative Care accelerates its work to deliver impactful innovations to patients at the most tenuous moments of their lives,” said Petrovic. “My experience serving on the Imperative Care Board has been quite inspirational as the company engineers solutions to some of the greatest challenges in medicine through medtech and digital health innovations.”
About
Imperative Care is a commercial-stage medical technology company researching and developing connected innovations to elevate care for people affected by devastating vascular diseases such as stroke and pulmonary embolism. The company is focused on addressing specific gaps in treatment and care to make an impact across the entire patient journey. Imperative Care is based in
Legal Disclaimer / Forward-Looking Statements
This press release is not an offer to sell securities or a solicitation of an offer to buy any securities, and may not be relied upon in connection with the purchase or sale of any company security. This release may contain forward-looking statements regarding plans for future financing, projected business performance, future innovations and improvement of patient outcomes. Such statements are forward-looking statements and there can be no assurance that the results stated or implied by these forward-looking statements will actually be realized or achieved by the company. Forward-looking statements may be based on management assumptions that could prove to be wrong. The company’s predictions may not be realized for a variety of reasons as the company’s business is subject to substantial risks and potential events beyond its control that could cause material differences between predicted and actual results.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240725822876/en/
Investor:
Imperative
408-476-1672
mgarrett@imperativecare.com
Media:
Imperative
925-324-9846
jchow@imperativecare.com
Source: